Searched for
CONCORD BIOTECH
Bonus issue alert! Last day to buy this Rakesh Jhunjhunwala-backed smallcap pharma stock for 1:1 bonus bonanzaAs per Sebi's T+1 settlement cycle, investors must buy the company's shares at least one trading day before the record date for them to be ...- Ahead of Market: 10 things that will decide stock market action on TuesdayIndian stock markets surged nearly 2% on November 2, with Sensex gaining 1,233 points and Nifty rising 388 points. Falling crude oil prices...
- Bonus issues, stock splits, dividends: Infosys, Asian Paints among over 40 stocks turning ex-date this weekMore than 40 companies have scheduled record dates for dividends, bonus issues, rights issues and stock splits during November 2–6, 2026. M...
- Ahead of Market: 10 things that will decide stock market action on ThursdayIndian markets closed lower on Wednesday as rising crude oil prices and Middle East tensions hurt sentiment. Sensex fell 353 points to 73,2...
- Stocks in news: Paytm, Tata Consumer, Dalmia Bharat, REC and DCM ShriramIndian equity markets showed recovery with a rise in NSE Nifty 50, ending a four-session losing streak. Several companies reported their Se...
- Stocks in news: Bharat Dynamics, NTPC, Canara Bank and Waaree EnergiesIndian equity benchmarks experienced gains on Wednesday, driven by widespread buying in the market. Investors reacted positively to signs o...
- Ahead of Market: 10 things that will decide stock market action on TuesdayIndian equities gained on Monday as cooling oil prices and positive global cues lifted sentiment. Sensex rose 564 points to 74,859, while N...
- Samir Arora-backed Helios Mid Cap Fund exits Dixon Technologies, 2 others; adds 7 stocksHelios Mid Cap Fund, backed by Samir Arora, exited Dixon Technologies, Aadhar Housing Finance and Black Box in August. The fund added eight...
- Market Trading Guide: Hindustan Copper among 2 stock recommendations for TuesdayAnalysts recommend Hindustan Copper and Concord Biotech after both stocks broke key resistance levels with strong price action, volume and ...
- Stock Radar: Concord Biotech stock showing signs of rebound after falling over 20% from highs; time to buy?Concord Biotech stock shows a breakout from a seven-month consolidation phase. Experts suggest buying the stock for a target above 1,500 le...
- Concord Biotech shares jump 8% on USFDA nod for Mycophenolate Mofetil oral suspensionConcord Biotech shares saw a significant jump on Wednesday. This surge followed the company's announcement of receiving approval from the U...
- Concord Biotech shares tumble 16% after weak Q3 earningsConcord Biotech shares fell 16% to Rs 1,777.7 after the company reported a 2.1% YoY decline in Q3 FY25 net profit to Rs 75.92 crore, despit...
- Concord Biotech shares list at a healthy premium. What should investors do?Concord Biotech is a biotechnology company and a leading maker of select fermentation-based APIs across immunosuppressants and oncology in ...
- Concord Biotech shares list at 21% premium over IPO priceConcord Biotech is a biotechnology company and a leading maker of select fermentation-based APIs across immunosuppressants and oncology in ...
- Concord Biotech to list on Friday. Here’s what GMP suggestsAnalysts are of the opinion that a market premium of over 15% on the issue price is justified based on the company's business model, which ...
- Concord Biotech IPO opens. Should you subscribe to the issue?Analysts advised investors to subscribe to Concord Biotech IPO given its complex product portfolio, presence in niche space, strong client ...
- Concord Biotech IPO to open on August 4. Here are 10 things to know about the offerThe initial public offering (IPO) of Concord Biotech will open for subscription on August 4. The issue closes on August 8. The company's sh...
- Jhunjhunwala-backed Concord Biotech sets IPO price band at Rs 705-741According to the draft papers, Concord Biotech's IPO is entirely an offer for sale of (OFS) of 2,09,25,652 equity shares by Helix Investmen...
- Concord Biotech files DRHP with Sebi for Rs 2,000-2,500 cr IPOSources told ET that the IPO would be of ₹2000 crore - ₹2500 crore size.The issue with a face value of ₹1 per equity share is a complete of...
- Rare Enterprises, Quadria-backed Concord Biotech files draft IPO papers with SebiAs per an F&S report, Concord Biotech commands a market share of over 20 per cent by volume in 2021 across identified fermentation-based AP...
Load More
